massively parallel sequencing

AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.

The firms will develop multiple NGS-based companion diagnostic tests based on the Oncomine Dx Express Test and Oncomine Dx Target Test.

The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.